Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

MYX.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: October 18, 2025

Report Source: 2025 Annual Report

Analyst's Ratings for Mayne Pharma Group Ltd (MYX.AX)

Based on 5 analysts giving stock ratings to Mayne Pharma Group Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
20
Buy
60
Hold
20
Sell
0
Strong Sell
0
Mayne Pharma Group Ltd

Mayne Pharma Group Ltd. Stock Analysis MYX.AX

Australia Health Care Micro Cap Report:
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. The company is headquartered in Adelaide, South Australia and currently employs 450 full-time employees. The company went IPO on 2007-06-29. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The firm's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others. Its subsidiaries include Mayne Pharma International Pty Ltd, Mayne Holdings US Inc, Mayne Pharma LLC, and others.
Read More

Mayne Pharma Group Ltd (MYX.AX) Chart

Key Statistics of Mayne Pharma Group Ltd (MYX.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD2.32AUD2.40

Today's Open

AUD2.34

Volume

123.65K

P/E Ratio (TTM)

-

52 Week Range

AUD2.04AUD6.50

Market Cap

186.05M

Avg. Volume

27.09K

Dividend Yield

-

Financial Metrics & Statements of Mayne Pharma Group Ltd (MYX.AX)

FAQ's for Mayne Pharma Group Ltd (MYX.AX)

  • According to Musaffa’s Shariah screening methodology, Mayne Pharma Group Ltd (MYX.AX) is currently classified as HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mayne Pharma Group Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Mayne Pharma Group Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Mayne Pharma Group Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Mayne Pharma Group Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Mayne Pharma Group Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.